NEOG - Neogen Corporation
NASDAQ
->
Healthcare
->
Diagnostics & Research
Lansing,
United States
Type: Equity
NEOG price evolution
NEOG
| (in millions $) | 1 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $170.61 | $161.44 | $205.76 | |
| Short term investments | $0.33 | $7.01 | $24.5 | |
| Net receivables | $167.64 | $173 | $173.59 | $150.5 |
| Inventory | $198.6 | $189.27 | $182.39 | $160.53 |
| Total current assets | $540.65 | $589.23 | $602.47 | $624.37 |
| Long term investments | ||||
| Property, plant & equipment | $315.28 | $291.89 | $287.58 | $259.31 |
| Goodwill & intangible assets | $3647.28 | $3676.08 | $3702.73 | |
| Total noncurrent assets | $3959.6 | $3980.02 | $3978.04 | |
| Total investments | $0.33 | $7.01 | $24.5 | |
| Total assets | $4503.17 | $4548.83 | $4582.49 | $4602.41 |
| Current liabilities | ||||
| Accounts payable | $61.46 | $83.06 | $89.75 | $112.18 |
| Deferred revenue | $4.63 | $5.49 | $4.68 | |
| Short long term debt | $2.45 | $2.52 | $2.57 | |
| Total current liabilities | $122.69 | $154.32 | $157.84 | $176.61 |
| Long term debt | $889.13 | $888.39 | $887.65 | $886.91 |
| Total noncurrent liabilities | $1250.37 | $1278.47 | $1278.24 | |
| Total debt | $890.84 | $890.17 | $889.48 | |
| Total liabilities | $1367.98 | $1404.69 | $1436.32 | $1454.85 |
| Shareholders' equity | ||||
| Retained earnings | $543.01 | $555.62 | $561.03 | $563.06 |
| Other shareholder equity | -$31.42 | -$30.02 | -$29.47 | -$25.13 |
| Total shareholder equity | $3144.14 | $3146.17 | $3147.57 | |
| (in millions $) | 31 Dec 2024 | 1 Jul 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $170.61 | $163.24 | $44.47 | $75.6 |
| Short term investments | $0.33 | $82.33 | $336.58 | $305.49 |
| Net receivables | $173 | $153.25 | $99.67 | $91.82 |
| Inventory | $189.27 | $133.81 | $122.31 | $100.7 |
| Total current assets | $589.23 | $585.93 | $626.8 | $591.45 |
| Long term investments | ||||
| Property, plant & equipment | $291.89 | $198.75 | $113.77 | $102.93 |
| Goodwill & intangible assets | $3647.28 | $3742.6 | $250.21 | $223.79 |
| Total noncurrent assets | $3959.6 | $3968.5 | $366.13 | $328.74 |
| Total investments | $0.33 | $82.33 | $336.58 | $305.49 |
| Total assets | $4548.83 | $4554.43 | $992.93 | $920.19 |
| Current liabilities | ||||
| Accounts payable | $83.06 | $76.67 | $34.61 | $23.9 |
| Deferred revenue | $4.63 | $4.62 | $5.46 | |
| Short long term debt | $2.45 | |||
| Total current liabilities | $154.32 | $145.47 | $77.84 | $53.6 |
| Long term debt | $888.39 | $885.44 | ||
| Total noncurrent liabilities | $1250.37 | $1274.74 | $27.71 | $26.22 |
| Total debt | $890.84 | $885.44 | ||
| Total liabilities | $1404.69 | $1420.21 | $105.56 | $79.81 |
| Shareholders' equity | ||||
| Retained earnings | $555.62 | $565.04 | $587.91 | $539.6 |
| Other shareholder equity | -$30.02 | $3134.22 | -$27.77 | -$11.38 |
| Total shareholder equity | $3144.14 | $3134.22 | $887.37 | $840.38 |
| (in millions $) | 1 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $216.96 | $236.79 | $229.63 | |
| Cost of revenue | $123.31 | $112.86 | ||
| Gross Profit | $104.93 | $113.48 | $116.77 | |
| Operating activities | ||||
| Research & development | $5.14 | $5.76 | ||
| Selling, general & administrative | $95.3 | $96.55 | ||
| Total operating expenses | $102.67 | $100.44 | $102.31 | |
| Operating income | $13.04 | $14.46 | ||
| Income from continuing operations | ||||
| EBIT | $12.22 | $14.29 | ||
| Income tax expense | -$3 | -$0.98 | -$0.26 | |
| Interest expense | -$17.62 | $18.62 | $18.03 | |
| Net income | ||||
| Net income | -$12.61 | -$5.42 | -$3.49 | |
| Income (for common shares) | -$5.42 | -$3.49 | ||
| (in millions $) | 31 Dec 2024 | 1 Jul 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $924.22 | $822.45 | $527.16 | $468.46 |
| Cost of revenue | $460.32 | $284.15 | $253.4 | |
| Gross Profit | $463.9 | $405.95 | $243.01 | $215.06 |
| Operating activities | ||||
| Research & development | $22.48 | $17.05 | $16.25 | |
| Selling, general & administrative | $382.76 | $167.35 | $124.64 | |
| Total operating expenses | $405.24 | $368.44 | $184.4 | $140.89 |
| Operating income | $58.66 | $58.62 | $74.17 | |
| Income from continuing operations | ||||
| EBIT | $59.09 | $60.21 | $75.27 | |
| Income tax expense | -$4.88 | $0.83 | $11.9 | $14.39 |
| Interest expense | $73.39 | |||
| Net income | ||||
| Net income | -$9.42 | -$22.87 | $48.31 | $60.88 |
| Income (for common shares) | -$9.42 | $48.31 | $60.88 | |
| (in millions $) | 1 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$5.42 | -$2.02 | -$3.49 | |
| Operating activities | ||||
| Depreciation | $33.37 | $29.65 | $29.47 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.94 | $3.68 | $3.51 | |
| Total cash flows from operations | $26.75 | -$30.21 | $15.71 | |
| Investing activities | ||||
| Capital expenditures | -$24.21 | -$32.13 | -$24.39 | |
| Investments | $6.68 | $17.49 | $35.92 | |
| Total cash flows from investing | -$33.66 | -$17.52 | -$14.64 | $11.54 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.01 | $1.3 | $0.08 | |
| Net borrowings | -$0.09 | -$0.06 | -$0.39 | |
| Total cash flows from financing | $0.98 | -$0.08 | $1.25 | -$0.31 |
| Effect of exchange rate | $0.46 | $0.53 | -$0.73 | -$0.01 |
| Change in cash and equivalents | -$50.13 | $9.17 | -$44.33 | $26.93 |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$9.42 | -$22.87 | $48.31 | $60.88 |
| Operating activities | ||||
| Depreciation | $121.23 | $88.38 | $23.69 | $21.04 |
| Business acquisitions & disposals | $11.72 | -$38.74 | -$50.77 | |
| Stock-based compensation | $13.77 | $10.18 | $7.15 | $6.44 |
| Total cash flows from operations | $35.26 | $41.03 | $68.04 | $81.09 |
| Investing activities | ||||
| Capital expenditures | -$111.31 | -$64.93 | -$24.43 | -$26.71 |
| Investments | $82 | $254.25 | -$34.05 | -$28.08 |
| Total cash flows from investing | -$29.31 | $201.04 | -$97.23 | -$105.56 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.46 | $1.2 | $7.93 | $34.63 |
| Net borrowings | -$0.54 | -$119.28 | ||
| Total cash flows from financing | $1.92 | -$118.08 | $6.81 | $33.54 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $7.37 | $118.77 | -$31.13 | $9.33 |
News
Fundamentals
| Market cap | $2.68B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 216.70M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | -5.25% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.45 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 4.41 |
| Quick ratio | 2.79 |